个人简介
Education Experience:
2004-2008 Ph. D. Biochemistry Martin-Luther University, Halle-Wittenberg,Germany
1995-1998 M.S. Microbial Pharmacy Shenyang Pharmaceutical University, China
1991-1995 Bachelor Microbial Pharmaceutics Shenyang Pharmaceutical University, China
Professional Experience:
2016- Associate Professor Tianjin University
2009-2016 Postdoctoral Fellow St. Jude Children's Research Hospital, USA
2008-2009 Postdoctoral Fellow Martin-Luther University, Halle-Wittenberg, Germany
2002-2003 UNESCO Course Participant Osaka University & Kyoto University, Japan
1998-2002 Lecture East China University of Science and Technology
Honors & Awards:
[1]Prize for Excellent Patent by Shanghai Bureau for Invention and Patent: 2002
[2]Participant of the 30th UNESCO Course in Microbiology: 2002-2003
研究领域
The research interest of Wu's Lab is to elucidate novel molecular mechanisms that underlie pathological neuronal death and neuronal regeneration and to provide the new therapeutic strategy to treat neurodegenerative disorders. Our primary interests focus on the novel mechanisms common in neuronal degeneration and regeneration contributed by a unique protein post-translational modification, polyglutamylation. Polyglutamylation is a dynamic process in which glutamate residues are added to the γ-carboxyl of a glutamate in the primary amino acid chain of substrate proteins by tubulin tyrosine ligase-like enzymes (TTLLs) and removed by the Cytosolic Carboxypeptidase (CCP) family. The prototype of CCP family, Nna1 (a.k.a CCP1) was discovered in an axon regeneration model and its dysfunction was later found underlying the phenotypes of Purkinje cell degeneration (pcd) mutant mice, in which certain types of neurons undergo progressive degeneration. Interestingly, a growing body of evidence shows that not only deficits of the catabolic process but also the anabolic process of polyglutamylation can cause varieties of neurodegenerative disorders, as well as other anormlies such as male infertility and defective hemostasis. Our lab uses genetically-manipulated mouse model combined with an array of methodologies of biochemistry, cell biology, and structural biology to reveal the genetic pathway and molecular insights that underlie the disorders caused by imbalanced polyglutamylation homeostasis. We are also interested in drug screen using neurodegeneration mouse models.
近期论文
查看导师新发文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
CCP5 and CCP6 retain CP110 and negatively regulate ciliogenesis
Yujuan Wang, Yuan Zhang, Xinyu Guo, Yiqiang Zheng, Xinjie Zhang, Shanshan Feng & Hui-Yuan Wu
BMC Biology volume 21, Article number: 124 (2023)
Facile purification of active recombinant mouse cytosolic carboxypeptidase 6 from Escherichia coli
Guo Xinyu,Wang Ruixue,Ma Ruifang,Fan Xiaona,Gao Yan,Zhang Xiangyang,Yuchi Zhiguang,Wu Hui-Yuan
Page:106112 ISSN:1046-5928 2022
Container-title:Protein Expression and Purification
A lysosome-targeted probe for the real-time detection of hypobromous acid in living human cancer cells
Wang Yali,Zhang Yuan,Yang Lijun,Wu Huiyuan,Finney Nathaniel
Page:2484-2489 ISSN:0003-2654 2021
Container-title:The Analyst
Effects of lysine 2-hydroxyisobutyrylation on bacterial FabI activity and resistance to triclosan
Biochimie
2021-03 | Journal article
DOI: 10.1016/j.biochi.2021.01.011
CONTRIBUTORS: Yiqiang Zheng; Hanyang Dong; Xue Bai; Hui Cui; Mulin Jun Li; Hui-Yuan Wu; Kai Zhang
Identification of 2-PMPA as a novel inhibitor of cytosolic carboxypeptidases
Wang Ruixue,Lin Lianyun,Zheng Yiqiang,Cao Peng,Yuchi Zhiguang,Wu Hui-Yuan
Page:1393-1399 ISSN:0006-291X 2020
Container-title:Biochemical and Biophysical Research Communications
Expression of recombinant mouse cytosolic carboxypeptidase 6 in Escherichia coli
Wang Ruixue,Wu Hui-Yuan
Page:04050 ISSN:2267-1242
Container-title:E3S Web of Conferences
https://doi.org/10.1051/e3sconf/202018504050
Identification of dual histone modification-binding protein interaction by combining mass spectrometry and isothermal titration calorimetric analysis
Journal of Advanced Research
2020-03 | Journal article
DOI: 10.1016/j.jare.2019.11.003
CONTRIBUTORS: Pu Chen; Zhenchang Guo; Cong Chen; Shanshan Tian; Xue Bai; Guijin Zhai; Zhenyi Ma; Huiyuan Wu; Kai Zhang